Tommaso Biancalani

Namkyeong Lee, Edward De Brouwer, Ehsan Hajiramezanali et al.

Recent advances in large language models (LLMs) have shown great potential to accelerate drug discovery. However, the specialized nature of biochemical data often necessitates costly domain-specific fine-tuning, posing major challenges. First, it hinders the application of more flexible general-purpose LLMs for cutting-edge drug discovery tasks. More importantly, it limits the rapid integration of the vast amounts of scientific data continuously generated through experiments and research. Compounding these challenges is the fact that real-world scientific questions are typically complex and open-ended, requiring reasoning beyond pattern matching or static knowledge retrieval.To address these challenges, we propose CLADD, a retrieval-augmented generation (RAG)-empowered agentic system tailored to drug discovery tasks. Through the collaboration of multiple LLM agents, CLADD dynamically retrieves information from biomedical knowledge bases, contextualizes query molecules, and integrates relevant evidence to generate responses - all without the need for domain-specific fine-tuning. Crucially, we tackle key obstacles in applying RAG workflows to biochemical data, including data heterogeneity, ambiguity, and multi-source integration. We demonstrate the flexibility and effectiveness of this framework across a variety of drug discovery tasks, showing that it outperforms general-purpose and domain-specific LLMs as well as traditional deep learning approaches. Our code is publicly available at https://github.com/Genentech/CLADD.

Hugues Van Assel, Mark Ibrahim, Tommaso Biancalani et al.

Reconstruction and joint embedding have emerged as two leading paradigms in Self Supervised Learning (SSL). Reconstruction methods focus on recovering the original sample from a different view in input space. On the other hand, joint embedding methods align the representations of different views in latent space. Both approaches offer compelling advantages, yet practitioners lack clear guidelines for choosing between them. In this work, we unveil the core mechanisms that distinguish each paradigm. By leveraging closed form solutions for both approaches, we precisely characterize how the view generation process, e.g. data augmentation, impacts the learned representations. We then demonstrate that, unlike supervised learning, both SSL paradigms require a minimal alignment between augmentations and irrelevant features to achieve asymptotic optimality with increasing sample size. Our findings indicate that in scenarios where these irrelevant features have a large magnitude, joint embedding methods are preferable because they impose a strictly weaker alignment condition compared to reconstruction based methods. These results not only clarify the trade offs between the two paradigms but also substantiate the empirical success of joint embedding approaches on real world challenging datasets.

Michael S. Yao, Osbert Bastani, Alma Andersson et al.

The goal of personalized medicine is to discover a treatment regimen that optimizes a patient's clinical outcome based on their personal genetic and environmental factors. However, candidate treatments cannot be arbitrarily administered to the patient to assess their efficacy; we often instead have access to an in silico surrogate model that approximates the true fitness of a proposed treatment. Unfortunately, such surrogate models have been shown to fail to generalize to previously unseen patient-treatment combinations. We hypothesize that domain-specific prior knowledge - such as medical textbooks and biomedical knowledge graphs - can provide a meaningful alternative signal of the fitness of proposed treatments. To this end, we introduce LLM-based Entropy-guided Optimization with kNowledgeable priors (LEON), a mathematically principled approach to leverage large language models (LLMs) as black-box optimizers without any task-specific fine-tuning, taking advantage of their ability to contextualize unstructured domain knowledge to propose personalized treatment plans in natural language. In practice, we implement LEON via 'optimization by prompting,' which uses LLMs as stochastic engines for proposing treatment designs. Experiments on real-world optimization tasks show LEON outperforms both traditional and LLM-based methods in proposing individualized treatments for patients.

Ying Yuan, Xing-Yue Monica Ge, Aaron Archer Waterman et al.

Large-scale single-cell and Perturb-seq investigations routinely involve clustering cells and subsequently annotating each cluster with Gene-Ontology (GO) terms to elucidate the underlying biological programs. However, both stages, resolution selection and functional annotation, are inherently subjective, relying on heuristics and expert curation. We present HYPOGENEAGENT, a large language model (LLM)-driven framework, transforming cluster annotation into a quantitatively optimizable task. Initially, an LLM functioning as a gene-set analyst analyzes the content of each gene program or perturbation module and generates a ranked list of GO-based hypotheses, accompanied by calibrated confidence scores. Subsequently, we embed every predicted description with a sentence-embedding model, compute pair-wise cosine similarities, and let the agent referee panel score (i) the internal consistency of the predictions, high average similarity within the same cluster, termed intra-cluster agreement (ii) their external distinctiveness, low similarity between clusters, termed inter-cluster separation. These two quantities are combined to produce an agent-derived resolution score, which is maximized when clusters exhibit simultaneous coherence and mutual exclusivity. When applied to a public K562 CRISPRi Perturb-seq dataset as a preliminary test, our Resolution Score selects clustering granularities that exhibit alignment with known pathway compared to classical metrics such silhouette score, modularity score for gene functional enrichment summary. These findings establish LLM agents as objective adjudicators of cluster resolution and functional annotation, thereby paving the way for fully automated, context-aware interpretation pipelines in single-cell multi-omics studies.